The Gross Margin of Akebia Therapeutics Inc (AKBA) is 83.67%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 83.67% |
| 2023-12-31 | 79.58% |
| 2022-12-31 | 92.31% |
| 2021-12-31 | 51.30% |
| 2020-12-31 | 55.13% |
| 2019-12-31 | 66.42% |
| 2018-12-31 | 96.97% |
| 2017-12-31 | 100.00% |